Boston Scientific BSX is gaining traction in the emerging markets. New regulatory approvals bode well for the company’s growth. The stock carries a Zacks Rank #2 (Buy) currently. Boston ...

Boston Scientific BSX is gaining traction in the international markets. New regulatory approvals and accretive acquisitions bode well for long-term growth. The stock carries a Zacks Rank #2 (Buy ...

Boston Scientific’s Strategic Resilience and Innovation Drive Buy Rating Amidst ACURATE IDE Challenges. TipRanks. Oct. 31, 2024, 07:20 AM.

In a report released on August 28, David Rescott from Robert W. Baird assigned a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $91.00. David Rescott has given ...

Boston Scientific BSX is gaining traction in the emerging markets. New regulatory approvals bode well for the company’s growth. The stock carries a Zacks Rank #2 (Buy) currently.

Boston Scientific BSX is gaining traction in the international markets. ... Boston Scientific Stock Gains From Market Expansion, Innovation November 01, 2024 — 09:13 am EDT.

Boston Scientific (BSX) Banks on Global Expansion, Innovation. Zacks Equity Research . Mon, Jul 22, 2024, 11:38 AM 4 min read. In This Article: BSX . HOLX . ELV . Boston Scientific BSX is gaining ...

Boston Scientific BSX is gaining traction in the international markets. New regulatory approvals and accretive acquisitions bode well for long-term growth. The stock carries a Zacks Rank #2 (Buy ...